# Title

 Commercial Practices. PART 1700â€”POISON PREVENTION PACKAGING


# ID

 CFR-2018-title16-vol2.Pt. 1700


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                             |
|:------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Money       | [(25.0, 'GBP')]                                                                                                                                                                                                                                                                                                    |
| Constraints | ['within', 'after', 'maximum of', 'no more than', 'before', 'greater', 'at least', 'prior to', 'later than', 'more than', 'exceed', 'less than']                                                                                                                                                                   |
| Duration    | ['180.0 day', '10.0 minute', '5.0 minute', '59.0 year', '1.0 minute', '51.0 month', '5 minute', '54.0 year', '1.0 year', '5.0 year', '49.0 month', '70.0 year', '72.0 hour', '48.0 month', '44.0 month', '1.0 month']                                                                                              |
| Condition   | ['subject to', 'provided that', 'unless', 'if', 'where', 'when']                                                                                                                                                                                                                                                   |
| Entities    | ['Seventy', 'East', 'Nonemulsion', 'Child', 'Methacrylic', 'Home', 'Poison', 'Thirty', 'Ketoprofen', 'Colesevelam', 'U.S.P', 'Ibuprofen', 'Sacrosidase', 'Household', 'Naproxen', 'Minoxidil', 'Washington, DC', 'Liquid', 'Further', 'Authority', 'Turpentine', 'Specific', 'Application', 'Sample', 'Mouthwash'] |
| Date        | ['1985-02-11', '1990-08-03', '1986-06-23', '2032-03-01', '2018-01-08', '2018-03-16', '2050-05-01', '1974-06-01', '2002-01-29', '1970-12-30', '2018-01-02', '2048-01-01', '2018-01-04', '2018-01-16']                                                                                                               |


# Structured Analysis With Context

 


## Money

| Money         | Context                                                                                                                                                  |
|:--------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------|
| (25.0, 'GBP') | The determination of the amount of a substance that may produce serious personal injury or serious illness shall be based on a 25-pound (11.4 kg) child. |


## Constraints

| Constraints   | Context                                                                                                                             |
|:--------------|:------------------------------------------------------------------------------------------------------------------------------------|
| within        | or harmful amount of the substance contained therein within a reasonable time and not difficult for normal                          |
| within        | or harmful amount of the substance contained therein within a reasonable time and not difficult for normal                          |
| after         | to section 3 of the act, the Commission, after consultation with the technical advisory committee provided for                      |
| later than    | shall not be sooner than 180 days or later than 1 year from the date the standard is                                                |
| after         | apply only to household substances packaged on and after  its effective date.                                                       |
| more than     | If a package bears  more than one principal display panel, the required statement shall                                             |
| within        | (3) The required labeling statement shall appear  within the borderline of a square or rectangle on                                 |
| less than     | complying with the following type-size specifications: (i) Not less than 1/16 inch in height on packages the principal              |
| less than     | (ii) Not  less than 3/32 inch in height on packages the principal                                                                   |
| more than     | display panel of which has an area of more than  7 but not                                                                          |
| more than     | display panel of which has an area of more than  7 but not                                                                          |
| less than     | (iii) Not  less than 1/8 inch in height on packages the principal                                                                   |
| more than     | display panel of which has an area of more than  15 but not                                                                         |
| more than     | display panel of which has an area of more than  15 but not                                                                         |
| less than     | (iv) Not  less than 3/16 inch in height on packages the principal                                                                   |
| more than     | display panel of which has an area of more than  25 but not                                                                         |
| more than     | display panel of which has an area of more than  25 but not                                                                         |
| less than     | (v) Not  less than 1/4 inch in height on packages the principal                                                                     |
| more than     | display panel of which has an area of more than  100 square inches.                                                                 |
| within        | appear on the principal display panel shall appear within that 40 percent of the circumference most likely                          |
| more than     | pediatric use, provided the dry tablet contains not more than 15 percent aspirin and has an oral LD-50                              |
| more than     | that are packaged in unit doses providing not more than 15.4 grains of aspirin per unit dose and                                    |
| less than     | other petroleum distillates and having a viscosity of less than 100 Saybolt universal seconds at 100 &#176;F., other                |
| more than     | Liquid preparations containing  more than 5 percent by weight of methyl salicylate, other                                           |
| less than     | of petroleum distillates and have a viscosity of less than 100 Saybolt universal seconds at 100 &#176;F., shall                     |
| more than     | suspension and oral suspensions in packages containing not more than  8 grams of the equivalent of erythromycin.                    |
| more than     | and powdered potassium in unit-dose packets, containing not more than  50 milliequivalents of potassium per unit dose.              |
| more than     | preparations including liquid and tablet forms, containing not more than 110 milligrams of sodium fluoride (the equivalent of       |
| more than     | preparations including liquid and tablet forms, containing not more than 110 milligrams of sodium fluoride (the equivalent of       |
| no more than  | Betamethasone tablets packaged in manufacturers' dispenser packages, containing no more than  12.6 milligrams betamethasone.        |
| no more than  | in tablet form, when dispensed in packages containing no more than  105 mg.                                                         |
| more than     | Mebendazole in tablet form in packages containing not more than  600 mg.                                                            |
| more than     | Methylprednisolone in tablet form in packages containing not more than 84 mg of the drug and containing no                          |
| more than     | Colestipol in powder form in packages containing not more than 5 grams of the drug and containing no                                |
| no more than  | (xvi) Erythromycin ethylsuccinate tablets in packages containing  no more than  the equivalent of 16 grams erythromycin.            |
| more than     | U.S.P., when dispensed in mnemonic packages containing not more than 32.0 mg of the drug and containing no                          |
| more than     | U.S.P., when dispensed in mnemonic packages containing not more than 50 mg of the drug and containing no                            |
| more than     | hydrochloride in powder form in packages containing not more than  3.75 grams of the drug.                                          |
| more than     | carbonate in powder form in packages containing not more than  2.4 grams of the drug.                                               |
| after         | by weight of ethylene glycol packaged on or after June 1, 1974, except those articles exempted by                                   |
| no more than  | as a colorant; and (ii) Powdered preparations with no more than  the equivalent of 0.12 percent weight-to-weight elemental iron.    |
| less than     | combinations thereof, and that have a viscosity of less than 100 Saybolt universal seconds at 100 &#176;F., shall                   |
| more than     | containing in a single package a total of more than one gram acetaminophen shall be packaged in accordance                          |
| less than     | acetaminophen, provided the dry tablet or granules contain less than 15 percent acetaminophen, the tablet or granules have          |
| greater       | have an oral LD-50 of 5 grams or greater per kilogram of body weight, and the tablet                                                |
| more than     | that are packaged in unit doses providing not more than 13 grains of acetaminophen per unit dose and                                |
| more than     | dosage form intended for oral administration and containing more than the equivalent of 66 mg diphenhydramine base in               |
| after         | (a), (b), and (c), if packaged on or after  February 11, 1985.                                                                      |
| more than     | Household glue removers in a liquid form containing  more than  500 mg of acetonitrile in a single container.                       |
| more than     | in a liquid form, containing in single container more than  600 mg of sodium bromate or                                             |
| more than     | in a liquid form, containing in single container more than  600 mg of sodium bromate or                                             |
| more than     | dosage form intended for oral administration and containing more than 0.045 mg of loperamide in a single package                    |
| at least      | Mouthwash products with nonremovable pump dispensers that contain  at least 7% on a weight-to-weight basis of mint or               |
| no more than  | of mint or cinnamon flavoring oils, that dispense no more than 0.03 grams of absolute ethanol per pump actuation,                   |
| less than     | absolute ethanol per pump actuation, and that contain less than 15 grams of ethanol in a single unit                                |
| more than     | Products containing  more than 5.0 mg of lidocaine in a single package                                                              |
| more than     | Products containing  more than 0.5 mg of dibucaine in a single package                                                              |
| more than     | Ketoprofen preparations for human use and containing  more than 50 mg of ketoprofen in a single retail                              |
| more than     | Household substances containing  more than the equivalent of 50 milligrams of elemental fluoride                                    |
| more than     | Household substances containing  more than the equivalent of 50 milligrams of elemental fluoride                                    |
| more than     | Minoxidil preparations for human use and containing  more than 14 mg of minoxidil in a single retail                                |
| more than     | in the following sentence, liquid household products containing more than 5 percent methacrylic acid (weight-to-volume) in a single |
| within        | absorbent material so that no free liquid is within the device, and (ii) under any reasonably foreseeable                           |
| before        | Food and Drug Administration (FDA) by any entity before  January 29, 2002.                                                          |
| less than     | hydrocarbons by weight and have a viscosity of less than 100 SUS at 100 &#176;F, shall be packaged                                  |
| less than     | hydrocarbons by weight and have a viscosity of less than 100 SUS at 100 &#176;F, shall be packaged                                  |
| within        | following standards shall be regarded as &#8220;special packaging&#8221; within  the meaning of section 2(4) of the act.            |
| less than     | the following specifications: (1) Child-resistant effectiveness of not less than  85 percent without a demonstration and not        |
| less than     | the following specifications: (1) Child-resistant effectiveness of not less than  85 percent without a demonstration and not        |
| after         | a demonstration and not less than 80 percent after a demonstration of the proper means of opening                                   |
| less than     | case of unit packaging, child-resistant effectiveness of not less than  80 percent.                                                 |
| less than     | a senior adult use effectiveness (SAUE) of not less than  90% for the senior-adult panel test of &#167;&#8201;1700.20(a)(3).        |
| less than     | specified below, shall have an effectiveness of not less than  90% for the younger-adult test of &#167;&#8201;1700.20(a)(4).        |
| more than     | flow of liquid is so restricted that not more than 2 milliliters of the contents can be obtained                                    |
| prior to      | the package to be tested shall be removed prior to testing unless it is part of the package's                                       |
| at least      | by the testing agency, shall be properly secured at least 72 hours prior to beginning the test to                                   |
| prior to      | shall be properly secured at least 72 hours prior to beginning the test to allow the materials (e.g.,                               |
| no more than  | tested at or obtained from any given site. no more than                                                                             |
| exceed        | of girls in each age range shall not exceed 10% of the number of children in that                                                   |
| prior to      | child shall read and sign a consent form prior to  the child's participation.                                                       |
| more than     | a child who opens or gains access to more than 8 individual units, whichever number is lower, during                                |
| maximum of    | groups of 50 children each, up to a maximum of  200 children.                                                                       |
| more than     | No individual shall administer the test to  more than  30% of the children tested in each group.                                    |
| more than     | No child shall test  more than  two special packages.                                                                               |
| more than     | When  more than one special package is being tested, each package                                                                   |
| more than     | Not  more than 24% of the senior adults tested shall be                                                                             |
| more than     | No individual tester shall administer the test to  more than  35% of the senior adults tested.                                      |
| before        | CT closures shall have been resecured 72 hours before  testing at 10 inch-pounds of torque.                                         |
| more than     | Not  more than 35% of adults shall be obtained or tested                                                                            |
| more than     | No individual tester shall administer the test to  more than  35% of the adults tested.                                             |


## Duration

| Duration    | Context                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 5.0 year    | (4) Special packaging means packaging that is designed or constructed to be significantly difficult for children under 5 years of age to open or obtain a toxic or harmful amount of the substance contained therein within a reasonable time and not difficult for normal adults to use properly, but does not mean packaging which all such children cannot open or obtain a toxic or harmful amount within a reasonable time. |
| 180.0 day   | Section 9 of the act specifies that the effective date shall not be sooner than 180 days or later than 1 year from the date the standard is promulgated in the Federal Register unless the Commission, for good cause found, determines that an earlier effective date is in the public interest and publishes in the Federal Register the reason for such finding, in which case such earlier effective date shall apply.       |
| 1.0 year    | Section 9 of the act specifies that the effective date shall not be sooner than 180 days or later than 1 year from the date the standard is promulgated in the Federal Register unless the Commission, for good cause found, determines that an earlier effective date is in the public interest and publishes in the Federal Register the reason for such finding, in which case such earlier effective date shall apply.       |
| 72.0 hour   | In both the adult tests, reclosable packages, if assembled by the testing agency, shall be properly secured at least 72 hours prior to beginning the test to allow the materials (e.g., the closure liner) to &#8220;take a set.&#8221; If assembled by the testing agency, torque-dependent closures shall be secured at the same on-torque as applied on the packaging line.                                                   |
| 44.0 month  | Thirty percent of the children in each group shall be of age 42-44 months, 40% of the children in each group shall be of age 45-48 months, and 30% of the children in each group shall be of age 49-51 months.                                                                                                                                                                                                                   |
| 48.0 month  | Thirty percent of the children in each group shall be of age 42-44 months, 40% of the children in each group shall be of age 45-48 months, and 30% of the children in each group shall be of age 49-51 months.                                                                                                                                                                                                                   |
| 51.0 month  | Thirty percent of the children in each group shall be of age 42-44 months, 40% of the children in each group shall be of age 45-48 months, and 30% of the children in each group shall be of age 49-51 months.                                                                                                                                                                                                                   |
| 1.0 month   | This figure either will remain the same or be adjusted up or down by 1 month, depending on the number of days obtained in the subtraction of the birth date from the test date.                                                                                                                                                                                                                                                  |
| 1.0 month   | (4) If the number of days obtained by subtracting the days in the birth date from the days in the test date is + 16 or more, 1 month is added to the number of months obtained above.                                                                                                                                                                                                                                            |
| 1.0 month   | If the number of days is &#8722;16 or less, subtract 1 month.                                                                                                                                                                                                                                                                                                                                                                    |
| 49.0 month  | Thus, for the example given above, the number of days is &#8722;20, and the number of months is therefore 50 &#8722; 1 = 49 months.                                                                                                                                                                                                                                                                                              |
| 10.0 minute | In the case of unit packaging, however, a test failure shall be any child who opens or gains access to the number of individual units which constitute the amount that may produce serious personal injury or serious illness, or a child who opens or gains access to more than 8 individual units, whichever number is lower, during the full 10 minutes of testing.                                                           |
| 5.0 minute  | Table 1 gives the acceptance (pass), continue testing, and rejection (fail) criteria to be used for the first 5 minutes and the full 10 minutes of the children's test.                                                                                                                                                                                                                                                          |
| 10.0 minute | Table 1 gives the acceptance (pass), continue testing, and rejection (fail) criteria to be used for the first 5 minutes and the full 10 minutes of the children's test.                                                                                                                                                                                                                                                          |
| 54.0 year   | Twenty-five percent of the participants shall be 50-54 years of age, 25% of participants shall be 55-59 years of age, and 50% of the participants shall be 60-70 years old.                                                                                                                                                                                                                                                      |
| 59.0 year   | Twenty-five percent of the participants shall be 50-54 years of age, 25% of participants shall be 55-59 years of age, and 50% of the participants shall be 60-70 years old.                                                                                                                                                                                                                                                      |
| 70.0 year   | Twenty-five percent of the participants shall be 50-54 years of age, 25% of participants shall be 55-59 years of age, and 50% of the participants shall be 60-70 years old.                                                                                                                                                                                                                                                      |
| 54.0 year   | Seventy percent of the participants of ages 50-59 and ages 60-70 shall be female (17 or 18 females shall be apportioned to the 50-54 year age group).                                                                                                                                                                                                                                                                            |
| 5.0 minute  | Participants who are unable to open the packaging being tested in the first 5-minute time period, are given a screening test.                                                                                                                                                                                                                                                                                                    |
| 72.0 hour   | Each closure shall have a diameter of 28 mm&#177;18%, and the CT closures shall have been resecured 72 hours before testing at 10 inch-pounds of torque.                                                                                                                                                                                                                                                                         |
| 1.0 minute  | Persons who cannot open and close both of the screening packages in 1-minute screening tests shall not be counted as participants in the senior-adult panel.                                                                                                                                                                                                                                                                     |
| 5.0 minute  | The senior adult use effectiveness (SAUE) is the percentage of adults who both opened the package in the first (5-minute) test period and opened and (if appropriate) properly resecured the package in the 1-minute test period.                                                                                                                                                                                                |
| 1.0 minute  | The senior adult use effectiveness (SAUE) is the percentage of adults who both opened the package in the first (5-minute) test period and opened and (if appropriate) properly resecured the package in the 1-minute test period.                                                                                                                                                                                                |
| 5 minute    | Five minutes shall be allowed to complete the opening and, if appropriate, the resecuring process.                                                                                                                                                                                                                                                                                                                               |


## Condition

| Condition     | Context                                                                                                                                |
|:--------------|:---------------------------------------------------------------------------------------------------------------------------------------|
| when          | (iii) A substance intended for use as fuel when stored in a portable container and used in                                             |
| unless        | ship or deliver any household substance to consumers unless  it is the only such container or wrapping.                                |
| if            | for the special packaging of any household substance if the Commission finds: (1) That the degree or                                   |
| unless        | the standard is promulgated in the Federal Register unless the Commission, for good cause found, determines that                       |
| subject to    | To make household substances that are  subject to requirements for special packaging readily available to elderly                      |
| provided that | substances in noncomplying packaging of a single size provided that complying packaging is also supplied and the noncomplying          |
| where         | that they should not be used in households where  young children are present.                                                          |
| subject to    | section, on the package of any household substance subject to the special packaging requirements of this part 1700                     |
| unless        | noncomplying packaging under section 4(a) of the act, unless the package bears the substitute labeling statement in                    |
| where         | (A) In the case of a rectangular package where one entire side properly can be considered to                                           |
| if            | of the total surface of the container; however, if such container presents an obvious principal display (such                          |
| subject to    | unit dose and that contain no other substance subject to  the provisions of this section.                                              |
| subject to    | in whole or in part of any substance subject to control under the Comprehensive Drug Abuse Prevention and                              |
| subject to    | basis for non-liquids and containing no other substances subject to  this &#167;&#8201;1700.14(a)(10).                                 |
| subject to    | or powder form and containing no other substances subject to  this &#167;&#8201;1700.14(a)(10).                                        |
| when          | (x) Prednisone in tablet form,  when dispensed in packages containing no more than 105                                                 |
| subject to    | of the drug, and containing no other substances  subject to  this &#167;&#8201;1700.14(a)(10).                                         |
| subject to    | of the drug, and containing no other substance  subject to  the provisions of this section.                                            |
| subject to    | of the drug and containing no other substance subject to  the provisions of this section.                                              |
| subject to    | of the drug and containing no other substance subject to  the provisions of this section.                                              |
| when          | (xvii) Conjugated Estrogens Tablets, U.S.P.,  when dispensed in mnemonic packages containing not more than                             |
| subject to    | of the drug and containing no other substances subject to  this &#167;&#8201;1700.14(a)(10).                                           |
| when          | (xviii) Norethindrone Acetate Tablets, U.S.P.,  when dispensed in mnemonic packages containing not more than                           |
| subject to    | of the drug and containing no other substances subject to  this &#167;&#8201;1700.14(a)(10).                                           |
| subject to    | the tablet or granules contain no other substance subject to  the provisions of this section.                                          |
| subject to    | unit dose and that contain no other substance subject to  this &#167;&#8201;1700.14(a).                                                |
| if            | the provisions of &#167;&#8201;1700.15 (a), (b), and (c), if  packaged on or after February 11, 1985.                                  |
| if            | This requirement does not apply  if the OTC drug product contains only active ingredients                                              |
| where         | spray device (e.g., aerosols, or pump-or trigger-actuated sprays where the pump or trigger mechanism has either a                      |
| where         | spray device (e.g., aerosols, or pump-or trigger-actuated sprays where the pump or trigger mechanism has either a                      |
| when          | (2) Sample packages should be submitted without contents  when such contents are unnecessary for demonstrating the effectiveness       |
| when          | set forth in paragraph (b) of this section when  in actual contact with the substance contained therein.                               |
| when          | (ii) Younger-adult test&#8212;(A) When applicable. when                                                                                |
| if            | be presumed not to require a metal container if the product, or another product of identical composition,                              |
| if            | with the SAUE requirements of &#167;&#8201;1700.20(a)(3) shall provide, if requested by the Commission's staff, a written explanation  |
| if            | staff will reply to the manufacturer or packager, if requested, stating the staff's views on the adequacy                              |
| subject to    | Special packaging for substances  subject to the provisions of this paragraph shall not be                                             |
| subject to    | Special packaging  subject to the provisions of this paragraph shall be special                                                        |
| when          | 2 milliliters of the contents can be obtained when the inverted, opened container is taken or squeezed                                 |
| when          | 2 milliliters of the contents can be obtained when the inverted, opened container is taken or squeezed                                 |
| unless        | be tested shall be removed prior to testing unless  it is part of the package's child-resistant design.                                |
| if            | (2) In both the adult tests,  if the outer package bears instructions for how to                                                       |
| if            | the times allowed for attempting to open and, if  appropriate, reclose the package.                                                    |
| if            | (3) In both the adult tests,  if the outer package does not bear any instructions                                                      |
| if            | In both the adult tests, reclosable packages,  if assembled by the testing agency, shall be properly                                   |
| if            | In both the adult tests, reclosable packages,  if assembled by the testing agency, shall be properly                                   |
| subject to    | children shall be randomly selected as to age, subject to  the limitations set forth below.                                            |
| when          | to the number of months that was obtained when the birth date was subtracted from the test                                             |
| if            | added to the number of months obtained above. if                                                                                       |
| if            | Further testing is required  if the results are inconclusive and involves the use                                                      |
| subject to    | adults shall be randomly selected as to age, subject to  the limitations set forth below.                                              |
| if            | shall be allowed to complete the opening and, if  appropriate, the resecuring process.                                                 |
| subject to    | the purpose of designating particular substances as being subject to the requirements for special packaging under the act              |
| where         | effectiveness and adult-use effectiveness required for each and, where appropriate, will include any other conditions deemed necessary |
| subject to    | manufacturers of special packaging, or producers of substances subject to regulations issued pursuant to the act, submit to            |
| where         | the Commission's staff and are recommended for use where  appropriate.                                                                 |
| where         | CPSC will use the adult-resecuring test  where an objective determination (e.g., visual or mechanical) that                            |


## Entities

| Entities       | Context                                                                                                  |
|:---------------|:---------------------------------------------------------------------------------------------------------|
| Authority      | Authority .                                                                                              |
| Nonemulsion    | Nonemulsion type liquid furniture polishes containing 10 percent or                                      |
| Liquid         | Liquid preparations containing more than 5 percent by weight                                             |
| Household      | Household substances in dry forms such as granules, powder,                                              |
| Turpentine     | (6)  Turpentine .                                                                                        |
| Household      | Household substances in liquid form containing 10 percent or                                             |
| Household      | Household substances in liquid form containing 4 percent or                                              |
| Household      | Household substances containing 10 percent or more by weight                                             |
| U.S.P          | (xvii) Conjugated Estrogens Tablets,  U.S.P ., when dispensed in mnemonic packages containing not        |
| U.S.P          | (xviii) Norethindrone Acetate Tablets,  U.S.P ., when dispensed in mnemonic packages containing not      |
| Sacrosidase    | (xx)  Sacrosidase (sucrase) preparations in a solution of glycerol and                                   |
| Colesevelam    | (xxii)  Colesevelam hydrochloride in powder form in packages containing not                              |
| Household      | Household substances in liquid form containing 10 percent or                                             |
| Household      | Household glue removers in a liquid form containing more                                                 |
| Home           | Home permanent wave neutralizers, in a liquid form, containing                                           |
| Ibuprofen      | Ibuprofen preparations for human use in a dosage form                                                    |
| Mouthwash      | Mouthwash products with nonremovable pump dispensers that contain at                                     |
| Naproxen       | Naproxen preparations for human use and containing the equivalent                                        |
| Ketoprofen     | Ketoprofen preparations for human use and containing more than                                           |
| Household      | Household substances containing more than the equivalent of 50                                           |
| Minoxidil      | Minoxidil preparations for human use and containing more than                                            |
| Methacrylic    | Methacrylic acid products applied by an absorbent material contained                                     |
| Sample         | Sample packages and labeling should be sent to the                                                       |
| East           | Consumer Product Safety Commission, Office of Compliance, 4330 East  West Highway, Washington, DC 20207. |
| Washington, DC | Commission, Office of Compliance, 4330 East West Highway, Washington, DC  20207.                         |
| Poison         | Poison  prevention packaging standards.                                                                  |
| Specific       | Specific application of these standards to substances requiring special                                  |
| Application    | Application  torques must be recorded in the test report.                                                |
| Child          | (2)  Child  test&#8212;(i) Test subjects&#8212;(A) Selection criteria.                                   |
| Thirty         | Thirty percent of the children in each group shall                                                       |
| Further        | Further testing is required if the results are inconclusive                                              |
| Seventy        | Seventy percent of the participants of ages 50-59 and                                                    |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                  |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1970-12-30 | 1670-74; 15 U.S.C. 1471-75), enacted December 30, 1970.                                                                                                                                                                                                                                                                                                  |
| 2018-01-16 | (4) The declaration shall be in letters in type size established in relationship to the area of the principal display panel of the package and shall be uniform for all packages of substantially the same size by complying with the following type-size specifications:                                                                                |
|            |             (i) Not less than 1/16 inch in height on packages the principal display panel of which has an area of 7 square inches or less.                                                                                                                                                                                                               |
| 2032-03-01 | (ii) Not less than 3/32 inch in height on packages the principal display panel of which has an area of more than 7 but not more than 15 square inches.                                                                                                                                                                                                   |
| 2018-01-08 | (iii) Not less than 1/8 inch in height on packages the principal display panel of which has an area of more than 15 but not more than 25 square inches.                                                                                                                                                                                                  |
| 2018-03-16 | (iv) Not less than 3/16 inch in height on packages the principal display panel of which has an area of more than 25 but not more than 100 square inches.                                                                                                                                                                                                 |
| 2018-01-04 | (v) Not less than 1/4 inch in height on packages the principal display panel of which has an area of more than 100 square inches.                                                                                                                                                                                                                        |
| 1974-06-01 | Household substances in liquid form containing 10 percent or more by weight of ethylene glycol packaged on or after June 1, 1974, except those articles exempted by 16 CFR 1500.83, shall be packaged in accordance with the provisions of &#167;&#8201;1700.15 (a) and (b).                                                                             |
| 2050-05-01 | Preparations for human use in a dosage form intended for oral administration and containing in a single package a total of more than one gram acetaminophen shall be packaged in accordance with the provisions of &#167;&#8201;1700.15 (a), (b), and (c), except the following&#8212;                                                                   |
|            |             (i) Effervescent tablets or granules containing acetaminophen, provided the dry tablet or granules contain less than 15 percent acetaminophen, the tablet or granules have an oral LD-50 of 5 grams or greater per kilogram of body weight, and the tablet or granules contain no other substance subject to the provisions of this section. |
| 1985-02-11 | Preparations for human use in a dosage form intended for oral administration and containing more than the equivalent of 66 mg diphenhydramine base in a single package shall be packaged in accordance with the provisions of &#167;&#8201;1700.15 (a), (b), and (c), if packaged on or after February 11, 1985.                                         |
| 2002-01-29 | This requirement does not apply if the OTC drug product contains only active ingredients of any oral drug product or products approved for OTC marketing based on an application for OTC marketing submitted to the Food and Drug Administration (FDA) by any entity before January 29, 2002.                                                            |
| 1990-08-03 | The children's ages in months shall be calculated as follows:                                                                                                                                                                                                                                                                                            |
|            |             (1) Arrange the birth date and test date by the numerical designations for month, day, and year (e.g., test date: 8/3/1990; birth date: 6/23/1986).                                                                                                                                                                                          |
| 1986-06-23 | The children's ages in months shall be calculated as follows:                                                                                                                                                                                                                                                                                            |
|            |             (1) Arrange the birth date and test date by the numerical designations for month, day, and year (e.g., test date: 8/3/1990; birth date: 6/23/1986).                                                                                                                                                                                          |
| 2048-01-01 | (e.g.,                                                                                                                                                                                                                                                                                                                                                   |
|            |             (3) Multiply the difference in years by 12 to obtain the number of months in the difference in years, and add this value to the number of months that was obtained when the birth date was subtracted from the test date (i.e., 4 &#215; 12 = 48; 48 + 2 = 50).                                                                              |
| 2018-01-02 | The containers for both the snap- and CT-type closures shall be round plastic containers, in sizes of 2 ounce&#177;1/2 ounce for the CT-type closure and 8 drams&#177;4 drams for the snap-type closure.                                                                                                                                                 |


